nickel has been researched along with prazosin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez, C; Bladé, C; Cartañà, J | 1 |
| Brain, KL; Cunnane, TC; Cuprian, AM; Williams, DJ | 1 |
2 other study(ies) available for nickel and prazosin
| Article | Year |
|---|---|
Alpha 2-adrenergic blockade prevents hyperglycemia and hepatic glutathione depletion in nickel-injected rats.
Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Female; Glucagon; Glutathione; Hyperglycemia; Insulin; Liver; Nickel; Phentolamine; Prazosin; Propranolol; Rats; Rats, Wistar; Yohimbine | 1993 |
The sources and sequestration of Ca(2+) contributing to neuroeffector Ca(2+) transients in the mouse vas deferens.
Topics: Adenosine Triphosphate; Animals; Caffeine; Calcium; Calcium Channels, T-Type; Calcium Signaling; Chelating Agents; Electric Stimulation; Electrophysiology; In Vitro Techniques; Indoles; Male; Mibefradil; Mice; Mice, Inbred BALB C; Microscopy, Confocal; Models, Biological; Muscle Contraction; Muscle, Smooth; Nickel; Prazosin; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2X; Ryanodine; Thapsigargin; Vas Deferens | 2003 |